Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-31
DOI
10.3389/fendo.2020.00505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach
- (2019) Suryaprakash Raichur et al. Molecular Metabolism
- Hepatic stellate cell activation: A source for bioactive lipids
- (2019) Igor O. Shmarakov et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- An ANGPTL4–ceramide–PKCζ axis mediates chronic glucocorticoid exposure–induced hepatic steatosis and hypertriglyceridemia in mice
- (2019) Tzu-Chieh Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ceramides bind VDAC2 to trigger mitochondrial apoptosis
- (2019) Shashank Dadsena et al. Nature Communications
- Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
- (2019) Mika Hilvo et al. EUROPEAN HEART JOURNAL
- Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
- (2019) Bhagirath Chaurasia et al. SCIENCE
- Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
- (2019) Claudio Tana et al. International Journal of Environmental Research and Public Health
- Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion – A step towards precision medicine
- (2019) Bernard Thorens et al. Molecular Metabolism
- Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
- (2019) Meng Jiang et al. Frontiers in Endocrinology
- Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis
- (2019) Rui-Xu Yang et al. Lipids in Health and Disease
- Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism
- (2019) Sophie A. Montandon et al. Scientific Reports
- Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
- (2019) Jorge Simon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease
- (2019) Annelise M. Poss et al. JOURNAL OF CLINICAL INVESTIGATION
- Non-alcoholic fatty liver disease: Insights from sphingolipidomics
- (2018) David J. Montefusco et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
- (2018) Rozenn N. Lemaitre et al. DIABETES
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
- (2018) Panu K. Luukkonen et al. DIABETES CARE
- To die or not to die: death signaling in nonalcoholic fatty liver disease
- (2018) Yuko Akazawa et al. JOURNAL OF GASTROENTEROLOGY
- Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
- (2018) Sharda S. Anroedh et al. JOURNAL OF LIPID RESEARCH
- Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
- (2018) Natalia Wasilewska et al. Lipids in Health and Disease
- PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease
- (2017) Nynke Simons et al. GASTROENTEROLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Exome-wide association study of plasma lipids in >300,000 individuals
- (2017) Dajiang J Liu et al. NATURE GENETICS
- Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans
- (2017) Leonore Wigger et al. Cell Reports
- Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis
- (2017) William L. Holland et al. Molecular Metabolism
- Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 CohortHighlights
- (2016) Aki S. Havulinna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Ceramide synthases in biomedical research
- (2016) Francesca Cingolani et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
- (2016) Panu K. Luukkonen et al. JOURNAL OF HEPATOLOGY
- Inverting the Topology of a Transmembrane Protein by Regulating the Translocation of the First Transmembrane Helix
- (2016) Qiuyue Chen et al. MOLECULAR CELL
- Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
- (2016) Shunquan Wu et al. Scientific Reports
- Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity
- (2015) S. Rodriguez-Cuenca et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis
- (2015) Jonathan Y. Xia et al. Cell Metabolism
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Dihydroceramides: From Bit Players to Lead Actors
- (2015) Monowarul Mobin Siddique et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PNPLA3 I148M variant in nonalcoholic fatty liver disease: Demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis
- (2015) Li-Zhen Chen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance
- (2014) Sarah M. Turpin et al. Cell Metabolism
- CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance
- (2014) Suryaprakash Raichur et al. Cell Metabolism
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Sustained Induction of Collagen Synthesis by TGF-β Requires Regulated Intramembrane Proteolysis of CREB3L1
- (2014) Qiuyue Chen et al. PLoS One
- Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin andPCSK9Deficiency
- (2013) Kirill Tarasov et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inhibition of ceramidede novosynthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease
- (2013) Krzysztof Kurek et al. LIVER INTERNATIONAL
- Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes
- (2012) Sarah Brice Russo et al. JOURNAL OF CLINICAL INVESTIGATION
- Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
- (2012) Bray Denard et al. eLife
- Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels
- (2011) Kittichai Promrat et al. HEPATOLOGY RESEARCH
- Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane
- (2010) Vidyaramanan Ganesan et al. APOPTOSIS
- Adiponectin: A Key Player in Obesity Related Disorders
- (2010) Yuji Matsuzawa CURRENT PHARMACEUTICAL DESIGN
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
- (2010) William L Holland et al. NATURE MEDICINE
- Inhibition of Sphingomyelin Hydrolysis: Targeting the Lipid Mediator Ceramide as a Key Regulator of Cellular Fate
- (2009) Ralf Claus et al. CURRENT MEDICINAL CHEMISTRY
- The plasma lipidomic signature of nonalcoholic steatohepatitis
- (2009) Puneet Puri et al. HEPATOLOGY
- Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
- (2009) Juichi Fukushima et al. HEPATOLOGY RESEARCH
- Involvement of Acid β-Glucosidase 1 in the Salvage Pathway of Ceramide Formation
- (2009) Kazuyuki Kitatani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease
- (2009) Zheng Zheng Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease
- (2009) Maud Lemoine et al. LIVER INTERNATIONAL
- Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
- (2009) Naim Alkhouri et al. Expert Review of Gastroenterology & Hepatology
- Hepatic triglyceride synthesis and nonalcoholic fatty liver disease
- (2008) Steve S Choi et al. CURRENT OPINION IN LIPIDOLOGY
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
- (2008) Catherine Postic et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More